Search Results - "Zander, Mette"

Effect of empagliflozin on coronary microvascular function in patients with type 2 diabetes mellitus-A randomized, placebo-controlled cross-over study by Suhrs, Hannah Elena, Nilsson, Malin, Bové, Kira Bang, Zander, Mette, Prescott, Eva

“…Results from large scale cardiovascular outcome trials in patients with type 2 diabetes mellitus (DM2) have found that sodium-glucose cotransporter 2…”
Get full text

The effect of DPP-4-protected GLP-1 (7–36) on coronary microvascular function in obese adults by Nilsson, Malin, Bové, Kira Bang, Suhrs, Elena, Hermann, Thomas, Madsbad, Sten, Holst, Jens Juul, Prescott, Eva, Zander, Mette

“…Glucagon-like-peptide-1 (GLP-1) receptor analogues have been shown to reduce cardiovascular events in patients with type 2 diabetes. However, the mechanism…”
Get full text

Additive Effects of Glucagon-Like Peptide 1 and Pioglitazone in Patients With Type 2 Diabetes by ZANDER, Mette, CHRISTIANSEN, Allan, MADSBAD, Sten, HOLST, Jens Juul

“…Additive Effects of Glucagon-Like Peptide 1 and Pioglitazone in Patients With Type 2 Diabetes Mette Zander , MD, PHD 1 2 , Allan Christiansen , MD 1 2 , Sten…”
Get full text

Video consultations as add-on to standard care among patients with type 2 diabetes not responding to standard regimens: a randomized controlled trial by Hansen, Caroline Raun, Perrild, Hans, Koefoed, Birgitte Gade, Zander, Mette

“…Objective To examine whether video consultations preceded by measurements of blood glucose, weight and blood pressure as add-on to standard care could…”
Get full text

Additive Glucose-Lowering Effects of Glucagon-Like Peptide-1 and Metformin in Type 2 Diabetes by ZANDER, Mette, TASKIRAN, Mustafa, TOFT-NIELSEN, Mai-Britt, MADSBAD, Sten, HOLST, Jens Juul

“…Additive Glucose-Lowering Effects of Glucagon-Like Peptide-1 and Metformin in Type 2 Diabetes Mette Zander , MD 1 2 , Mustafa Taskiran , MD 1 , Mai-Britt…”
Get full text

Experimental non-severe hypoglycaemia substantially impairs cognitive function in type 2 diabetes: a randomised crossover trial by Nilsson, Malin, Jensen, Nicole, Gejl, Michael, Bergmann, Marianne L., Storgaard, Heidi, Zander, Mette, Miskowiak, Kamilla, Rungby, Jørgen

“…Aims/hypothesis Previous studies have demonstrated a relationship between cognitive impairment and hypoglycaemia (<3 mmol/l). This study hypothesised that…”
Get full text

Effects of β-hydroxybutyrate on cognition in patients with type 2 diabetes by Jensen, Nicole Jacqueline, Nilsson, Malin, Ingerslev, Jonas Schultz, Olsen, Dorte Aalund, Fenger, Mogens, Svart, Mads, Møller, Niels, Zander, Mette, Miskowiak, Kamilla Woznica, Rungby, Jørgen

“…Objective Cognitive impairment in type 2 diabetes is associated with cerebral glucose hypometabolism. Providing a glucose substitute such as ketone bodies…”
Get full text

Effect of liraglutide on body weight and microvascular function in non-diabetic overweight women with coronary microvascular dysfunction by Suhrs, Hannah Elena, Raft, Kristoffer Flintholm, Bové, Kira, Madsbad, Steen, Holst, Jens Juul, Zander, Mette, Prescott, Eva

“…Coronary microvascular dysfunction (CMD) is associated with adverse cardiovascular outcomes and CMD is a hallmark of type 2 diabetes. Liraglutide improves…”
Get full text

Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes: a parallel-group study by Zander, Mette, Madsbad, Sten, Madsen, Jan Lysgaard, Holst, Jens Juul

“…Glucagon-like peptide 1 (GLP-1) has been proposed as a treatment for type 2 diabetes. We have investigated the long-term effects of continuous administration…”
Get full text

368-P: Effects of Mild Hypoglycaemia on Cognitive Function in Type 2 Diabetes by NILSSON, MALIN, JENSEN, NICOLE J., GEJL, MICHAEL, BRANDSLUND, IVAN, STORGAARD, HEIDI, ZANDER, METTE, MISKOWIAK, KAMILLA, RUNGBY, JØRGEN

“…Background: Previous studies have demonstrated cognitive impairment during severe hypoglycaemia. This study provides quantitative results on cognitive function…”
Get full text

Effect of the glucagon-like peptide-1 analogue liraglutide on coronary microvascular function in patients with type 2 diabetes - a randomized, single-blinded, cross-over pilot study by Faber, Rebekka, Zander, Mette, Pena, Adam, Michelsen, Marie M, Mygind, Naja D, Prescott, Eva

“…Impaired coronary microcirculation is associated with a poor prognosis in patients with type 2 diabetes. In the absence of stenosis of major coronary arteries,…”
Get full text

Abstract 13697: Glucagon-like Peptide-1 Analogue Liraglutide Does Not Improve Microvascular Myocardial Function in Patients With Type 2 Diabetes - a Randomized, Single-blinded Cross Over Trial by Faber, Rebekka, Zander, Mette, Pena, Adam A, Michelsen, Marie M, Mygind, Naja D, Prescott, Eva

“…Abstract only Background: Impaired coronary microcirculation is associated with a poor prognosis in patients with type 2 diabetes. In the absence of stenosis…”
Get full text

Denmark's comparative position regarding health status, healthcare provision, self-management and social support: Diabetes Attitudes, Wishes and Needs second study (DAWN2) by HANSEN, ULLA MØLLER, JONES, ALLAN, ZANDER, METTE, WILLAING, INGRID

“…Aims:The aim of this study was to benchmark the Danish sample of the second Diabetes, Attitudes, Wishes and Needs (DAWN2) study with the global average in…”
Get full text

The psychological impact of living with diabetes: Descriptive findings from the DAWN2 study in Denmark by Jones, Allan, Olsen, Mette Zander, Perrild, Hans J.D, Willaing, Ingrid

“…Highlights • Taking insulin medication appears to be linked to poorer quality of life. • Taking insulin medication is a potential source of distress. • Half of…”
Get full text

Effects of telemedicine in the treatment of patients with type 2 diabetes--a study protocol by Hansen, Caroline Raun, Perrild, Hans, Koefoed, Birgitte Gade, Faurschou, Pernille, Høst, Dorte, Zander, Mette

“…Despite rehabilitation programmes offered to all patients with newly diagnosed type 2 diabetes in Denmark, a number of patients either never accomplish good…”
Get full text

The prevalence of type 2-diabetes in ethnic minorities by Zander, Mette, Hansen, Caroline Raun, Koefoed, Birgitte Gade, Perrild, Hans

“…In general, type 2 diabetes is more common among immigrants than among the inhabitants with a Western background. The higher prevalence among ethnic minorities…”
Get more information

Effect of 4 Weeks of Near-Normalization of Blood Glucose on Beta-Cell Sensitivity to Glucose and GLP-1 in Type 2 Diabetic Patients by Højberg, Patricia V, Zander, Mette, Vilsbøll, Tina, Knop, Filip K

Get full text

Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and (beta)-cell function in type 2 diabetes: A parallel-group study by Zander, Mette, Madsbad, Sten, Lysgaard, Jan, Jens Juul Holst

“…Glucagon-like peptide 1 (GLP-1) has been proposed as a treatment for type 2 diabetes. We have investigated the long-term effects of continuous administration…”
Get full text

Subcutaneous GLP-1 reduces plasma glucose but may induce tachyphylaxis in type 2 diabetic patients by Zander, Mette, Madsbad, Sten, Holst, Jens J.

Get full text

Postprandial glycemic control with biphasic insulin aspart in patients with type 1 diabetes by Hermansen, Kjeld, Vaaler, Stein, Madsbad, Sten, Dalgaard, Marian, Zander, Mette, Begtrup, Kamilla, Soendergaard, Karsten

“…We sought to investigate the ability of biphasic insulin aspart 30 (BIAsp 30) to control postprandial hyperglycemia and hyperlipidemia in a meal-test…”
Get full text